Vaccine

An expert committee has recommended Phase I clinical trials for the vaccine developed by Indian Immunologicals and Australia's Griffith University, following a review of non-clinical studies

Updated On: 15 Nov 2026 | 12:14 PM IST

US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.

Updated On: 02 Nov 2026 | 8:03 PM IST

The vaccine will be priced at €5.50 per dose from early 2027 under a Gavi-UNICEF agreement, with expected savings of $50 million through 2029

Updated On: 23 Oct 2026 | 2:02 PM IST

The filing for sitagliptin tablets in three strengths marks Morepen's entry into integrated finished-dose development and regulatory filings in the US market

Updated On: 28 Sep 2026 | 5:44 PM IST

Initial QDENGA doses for India to come from Germany; private-market launch planned in H1 2027

Updated On: 18 Sep 2026 | 11:52 PM IST

Grouping eyes more collaboration on treatment TB, NCD and mental health

Updated On: 12 Sep 2026 | 7:59 PM IST

Drug regulator flags a batch of widely used Abhayrab rabies vaccine as substandard and potentially spurious after it failed a potency test, a government document shows

Updated On: 05 Sep 2026 | 7:54 AM IST

Today's opinions examine India's climate diplomacy lessons, vaccine resistance amid medical advances, AI's real-world limitations, RSS outreach to Gen Z and the growing threat of cognitive warfare

Updated On: 08 Aug 2026 | 6:15 AM IST

Flaws in US vaccine policy could make it impossible to leverage technology in optimal ways to advance medical science

Updated On: 07 Aug 2026 | 10:11 PM IST

The adulation served to marginalise the contributions of others, none more so than Albert Sabin, whose competing polio vaccine proved essential in controlling the disease

Updated On: 02 Aug 2026 | 11:20 PM IST

India has approved its first dengue vaccine. Japan-based Takeda's *QDENGA* is now approved for people aged *4 to 60 years* and protects against all four dengue virus serotypes.

Updated On: 22 Jul 2026 | 2:02 PM IST
Icon Youtube

The vaccine has been approved for individuals aged 4-60 years and can be administered without prior dengue screening, marking India's first vaccine-based strategy against the disease

Updated On: 20 Jul 2026 | 9:07 PM IST

The agreement positions the Pune-based vaccine maker to manufacture the M72/AS01E TB vaccine candidate at scale if ongoing Phase III trials succeed and approvals are secured

Updated On: 16 Jul 2026 | 11:01 PM IST

A personalised mRNA vaccine may help the immune system fight pancreatic cancer for years, with early trial data showing reduced recurrence in some patients

Updated On: 20 Apr 2026 | 2:06 PM IST

With dengue rising across regions, doctors break down the vaccine's benefits, safety, and why mosquito control still remains essential

Updated On: 03 Apr 2026 | 1:24 PM IST

A federal judge in Boston has temporarily blocked federal health officials from cutting the number of vaccines recommended for every child, and says U.S. Health Secretary Robert F. Kennedy Jr. likely violated federal procedures in revamping a key vaccine advisory committee. The decision Monday halts an order by Kennedy - announced in January - to end broad recommendations for all children to be vaccinated against flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis and RSV. Leading medical groups voiced alarm at the changes. The American Academy of Pediatrics and some other groups amended a lawsuit filed in July, asking the judge to stop the government from scaling back the nation's childhood vaccination schedule. The judge also says Kennedy's reconstitution of the vaccine advisory panel likely violated federal law. He ordered the appointments - and all decisions made by the reformed committee - put on hold.

Updated On: 17 Mar 2026 | 7:36 AM IST

A new study in mice explores a nasal vaccine approach that could offer broad protection against respiratory infections

Updated On: 02 Mar 2026 | 10:19 AM IST

Richard Hatchett, who leads the Cepi, a partnership of governments and philanthropies that was among the first to fund Covid-19 vaccines, said epidemics and pandemics remained a key global threat

Updated On: 13 Feb 2026 | 10:09 AM IST

Oral polio vaccines (OPVs) are safe, effective and central to global eradication efforts, but there is a need for improved immunisation to combat the emergence of vaccine-derived poliovirus strains, a US-based public health expert said. Referring to India's current status, Gates Foundation Deputy Director Dr Ananda Sankar Bandyopadhyay said paralytic outbreaks from circulating strains of variant polioviruses have not been detected in recent years, an indication that the country has been able to "maintain high routine immunisation coverage". Notably, India was certified polio-free in March 2014. "Oral polio vaccines (OPVs) are safe, effective, affordable, and easy to deliver. Use of OPV through routine immunisation and mass vaccination campaigns has eliminated poliovirus transmission and prevented paralysis in children across the world, with 99.9 per cent of the world polio-free," Bandyopadhyay told PTI from Seattle, USA. He said variant strains primarily emerge in areas with weak .

Updated On: 10 Feb 2026 | 2:24 PM IST

A Nipah vaccine developed at the University of Tokyo is set to enter human trials in April, as India reports fresh cases of the deadly virus that currently has no approved treatment

Updated On: 04 Feb 2026 | 9:59 AM IST